Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incorporation of the bone marker carboxy-terminal telopeptide of type-1 collagen improves prognostic information of the International Staging System in newly diagnosed symptomatic multiple myeloma.
Jakob C, Sterz J, Liebisch P, Mieth M, Rademacher J, Goerke A, Heider U, Fleissner C, Kaiser M, von Metzler I, Müller C, Sezer O. Jakob C, et al. Among authors: von metzler i. Leukemia. 2008 Sep;22(9):1767-72. doi: 10.1038/leu.2008.159. Epub 2008 Jun 26. Leukemia. 2008. PMID: 18580957
Bortezomib inhibits human osteoclastogenesis.
von Metzler I, Krebbel H, Hecht M, Manz RA, Fleissner C, Mieth M, Kaiser M, Jakob C, Sterz J, Kleeberg L, Heider U, Sezer O. von Metzler I, et al. Leukemia. 2007 Sep;21(9):2025-34. doi: 10.1038/sj.leu.2404806. Epub 2007 Jun 21. Leukemia. 2007. PMID: 17581612
Interactions of myeloma cells with osteoclasts promote tumour expansion and bone degradation through activation of a complex signalling network and upregulation of cathepsin K, matrix metalloproteinases (MMPs) and urokinase plasminogen activator (uPA).
Hecht M, von Metzler I, Sack K, Kaiser M, Sezer O. Hecht M, et al. Among authors: von metzler i. Exp Cell Res. 2008 Mar 10;314(5):1082-93. doi: 10.1016/j.yexcr.2007.10.021. Epub 2007 Nov 7. Exp Cell Res. 2008. PMID: 18053985
The potential of proteasome inhibitors in cancer therapy.
Sterz J, von Metzler I, Hahne JC, Lamottke B, Rademacher J, Heider U, Terpos E, Sezer O. Sterz J, et al. Among authors: von metzler i. Expert Opin Investig Drugs. 2008 Jun;17(6):879-95. doi: 10.1517/13543784.17.6.879. Expert Opin Investig Drugs. 2008. PMID: 18491989 Review.
32 results